Prevalence of human T-cell lymphotropic virus and the socio-demographic and risk factors associated with the infection among post-natal clinics women in Zaria, Nigeria

References

• Costa, C. M.; Goubau, P.; Liu, H. F.; Vandamme, A. M.; da-Cunha, F. M.; Santos, T. J.; Desmyter, J.; Carton, H. HTLV-negative and HTLV-1 like Positive Tropical Spastic Paraparesis in Northern Brazil. AIDS Res. Hum. Retrovirus. 1995, 11(2), 315–318. DOI: 10.1089/aid.1995.11.315.
   PubMed Web of Science ®Google Scholar
• Blattner, W. A. Epidemiology of HTLV-1 and Associated Disease: Human Retrovirology HTLV; Raven Press: New York, 1990; pp 252–263.
   Google Scholar
• Proietti, F. A.; Carneiro-Proietti, A. B. F.; Catalan-Soares, B. C.; Murphy, E. L. Global Epidemiology of HTLV-1 Infection and Associated Diseases. Oncogene. 2005, 24, 6058–6068. DOI: 10.1038/sj.onc.1208968.
   PubMed Web of Science ®Google Scholar
• Romanelli, L. F.; Caramelli, P.; Carneiro-Proietti, A. B. Human T-cell Lymphotrophic Virus Type 1 (HTLV-1): When to Suspect Infection? Revista Da Associacao Medica Bradileira. 2010, 56(3), 340–347. DOI: 10.1590/S0104-42302010000300021.
   PubMedGoogle Scholar
• Goncalves, D. U.; Proietti, F. A.; Ribas, J. G. Epidemiology, Treatment, and Prevention of Human T-cell Leukemia Virus Type 1-associated Diseases. Clin Microbiol Rev. 2010, 23(3), 577–589. DOI: 10.1128/CMR.00063-09.
   PubMed Web of Science ®Google Scholar
• Roucoux, D. F.; Murphy, E. L. The Epidemiology and Disease Outcomes of Human T Lymphotropic Virus Type II. AIDS Rev. 2004, 6(3), 144–154.
   PubMed Web of Science ®Google Scholar
• Martins, M. L.; Andrade, R. G.; Nedir, B. H.; Barbosa-Stanciolli, E. F. Human T-Lymphotrophic Virus (HTLV). Blood Transfusion Clin. Pract. 2012, 10, 175–186.
   Google Scholar
• Paiva, A.; Casseb, J. Origin and Prevalence of Human T-lymphotropic Virus Type 1 (htlv-1) and Type 2 (htlv-2) among Indigenous Populations in the Americas. Revista Do Instituto Medicina Tropical De Sao Paulo. 2015, 57(1), 1–13. DOI: 10.1590/S0036-46652015000100001.
   PubMed Web of Science ®Google Scholar
• Dumas, M.; Houinato, D.; Verdier, M.; Zohoun, T.; Josse, R.; Bonis, J.; Zohoun, I.; Massougbodji, A.; Denis, F. Seroepidemiology of humanT-cell Lymphotropic Virus Type I/II in Benin (west Africa). AIDS Res. Hum. Retroviruses. 1991, 7, 447–451. DOI: 10.1089/aid.1991.7.447.
   PubMed Web of Science ®Google Scholar
• Terry Alli, O. A.; Olusoga Ogbolu, D.; Oluremi, A. S.; Okanlawon, B. M. Seroprevalence of HTLV-I/II Amongst Blood Donors in Osogbo, Nigeria. Suda JMS. 2011, 6, 177–182.
   Google Scholar
• Durojaiye, I. O.; Akinsegun, A.; Dosunmu, A.; Ajibola, S.; Adediran, A.; Uche, E.; Oshinaike, O.; Odesanya, M.; Dada, A.; Okunoye, O. Seroprevalence of Human T Lymphotropic Virus Antibodies among Healthy Blood Donors at a Tertiary Centre in Lagos, Nigeria. Pan. Afr. Med. J. 2014, 17, 301. DOI: 10.11604/pamj.2014.17.301.4075.
   PubMedGoogle Scholar
• Forbi, J. C.; Odetunde, A. B. Human T-cell Lymphotrophic Virus in a Population of Pregnant Women and Commercial Sex Workers in South Western Nigeria. Afr. Health Sci. 2007, 7(3), 129–132. DOI: 10.5555/afhs.2007.7.3.129.
   PubMedGoogle Scholar
• Opaleye, O. O.; Igboama, M. C.; Ojo, J. A.; Odewale, G. Seroprevalence of HIV, HBV, HCV, and HTLV among Pregnant Women in Southwestern Nigeria. J. Immunoassay Immunochem. 2016, 37, 29–42. DOI: 10.1080/15321819.2015.1040160.
   PubMedGoogle Scholar
• Abu, R. J.; Olonitola, O. S.; Whong, C. M. Z.; Ella, E. E. Sero-prevalence of Human T-cell Leukaemia Virus Antibodies among Pregnant Women Attending Selected Hospitals in Zaria, Kaduna State. Bio. Environ. Sci. J. Tropics. 2014, 11(3), 179–184.
   Google Scholar
• Hino, S. Establishment of the Milk-borne Transmission as a Key Factor for the Peculiar Endemicity of Human T-lymphotropic Virus Type 1 (HTLV-1): The ATL Prevention Program Nagasaki. Proc. Jpn Acad. Ser. B Phys. Bio. Sci. 2011, 87, 152–166. DOI: 10.2183/pjab.87.152.
   PubMed Web of Science ®Google Scholar
• Moriuchi, H.; Masuzaki, H.; Doi, H.; Katamine, S. Mother-to-child Transmission of Human T-cell Lymphotropic Virus Type 1. Pediatr. Infect. Dis. J. 2013, 22(2), 175–177. DOI: 10.1097/INF.0b013e31827efc39.
   Google Scholar
• Paiva, A.; Casseb, J. Sexual Transmission of Human T-cell Lymphotropic Virus Type 1. Revista Da Sociedade Brasileira De Medicina Tropical. 2014, 47(3), 265–274.
   PubMed Web of Science ®Google Scholar
• Gotuzzo, E.; Sanchez, J.; Escamilla, J.; Carrillo, C.; Phillips, I. A.; Moreyra, L. Human T Cell Lymphotropic Virus Type I Infection among Female Sex Workers in Peru. J. Infect. Dis. 1994, 169, 754–759. DOI: 10.1093/infdis/169.4.754.
   PubMed Web of Science ®Google Scholar
• La Rosa, A. M.; Zunt, J. R.; Peinado, J.; Lama, J. R.; Ton, T. G.; Suarez, L. Retroviral Infection in Peruvian Men Who Have Sex with Men. Clin. Infect. Dis. 2009, 49, 112–117. DOI: 10.1086/599609.
   PubMed Web of Science ®Google Scholar
• Zehender, G.; Colasante, C.; De Maddalena, C.; Bernini, F.; Savasi, V.; Persico, T. High Prevalence of Human T-lymphotropic Virus Type 1 (HTLV-1) in Immigrant Male-to-female Transsexual Sex Workers with HIV-1 Infection. J. Med. Virol. 2004, 74, 207–215. DOI: 10.1002/jmv.20165.
   PubMed Web of Science ®Google Scholar
• Zunt, J.; La Rosa, A. M.; Peinado, J.; Lama, J. R.; Suarez, L.; Pun, M. Risk Factors for HTLV-II Infection in Peruvian Men Who Have Sex with Men. Am. J. Trop. Med. Hyg. 2006, 74, 922–925.
   PubMed Web of Science ®Google Scholar
• Oladimeji, J. S.; Ojibo, S. D. Governance Perceptions of Informal Enterprise Operators in Zaria, Nig. Am. Int. J. Contemp. Res. 2012, 2(10), 150–159.
   Google Scholar
• Kadam, P.; Bhalerao, S. Sample Size Calculation. Int. J. Ayurveda Res. 2010, 1(1), 55–57. DOI: 10.4103/0974-7788.59946.
   PubMedGoogle Scholar
• Adekunle, O. T.; Rotimi, T. O.; Alabi, B. L. Prevalence of Human T-lymphotropic Virus I and II among Patients Visiting Bowen University Clinic in Nigeria. Int. J. Health Sci. Res. 2015, 5(11), 115–118.
   Google Scholar
• Nasir, I. A.; Ahmad, A. E.; Emeribe, A. U.; Shehu, M. S.; Medugu, J. E.; Babayo, A. Molecular Detection and Clinical Implications of HTLV-1 Infections among Antiretroviral Therapy-naïve HIV-1-infected Individuals in Abuja, Nigeria. Virol. Res. Treat. 2015, 6, 17–23.
   PubMedGoogle Scholar
• Yuguda, S.; Manga, M. M.; Fowotade, A.; Chukwuma, O. E.; Aken, O. Y. Seroprevalence of Human T-Cell Lymphoma/Leukemia Virus Type-1(HTLV-1). J. Hum. Virol. Retrovirol. 2017, 5(5), 1–5. DOI: 10.15406/jhvrv.2017.05.00169.
   Google Scholar
• Verdonck, K.; González, E.; Van Dooren, S.; Vandamme, A. M.; Vanham, G.; Gotuzzo, E. J. Human T-lymphotropic Virus 1. Recent Knowledge about an Ancient Infection. Lancet Infect. Dis. 2007, 7, 266–281. DOI: 10.1016/S1473-3099(07)70081-6.
   PubMed Web of Science ®Google Scholar
• Manns, A.; Wilks, R. J.; Murphy, E. L.; Haynes, G.; Figueroa, J. P.; Barnett, M.; Hanchard, B.; Blattner, W. A. A Prospective Study of Transmission by Blood Transfusion of HTLV–1 and Risk Factors Associated with Seroconversion. Int. J. Cancer. 1992, 51, 886–891. DOI: 10.1002/ijc.2910510609.
   PubMed Web of Science ®Google Scholar
• Adamson, T. A.; Ogunlesi, A. O.; Morakinyo, O. L.; Akinhanmi, A. O.; Onifade, P. O.; Erinosho, O.; Adewuyi, A. A.; Fssiku, D. A.; Adebowale, T. O.; Ogunwale, A.; et al. Descriptive National Survey of Substance Use in Nigeria. J. Addict. Res. Ther. 2015, 6(3), 4–10. DOI: 10.4172/2155-6105.1000234.
   Google Scholar